NCT00482352

Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

Study Contact:

Study Phase:

Recruitment Status:

COMPLETED

NCT ID:

NCT00482352

Principal Investigator:

Study Type:

OBSERVATIONAL

Official Title:

Classification Of Acute Lymphoblastic Leukemia

Summary

This clinical trial is studying risk-group classification of patients with newly diagnosed acute lymphoblastic leukemia. Developing a risk-group classification guide may help doctors assign patients with newly diagnosed acute lymphoblastic leukemia to treatment clinical trials.

Eligibility

Inclusion Criteria:

* Newly diagnosed acute lymphoblastic leukemia, defined by any of the following:

* At least 25% blasts in the bone marrow
* Absolute blast count at least 10,000/mm\^3, if bone marrow aspiration is not performed
* No prior registration on this study

Disease(s) and\or Condition(s)

Untreated Adult Acute Lymphoblastic Leukemia

Untreated Childhood Acute Lymphoblastic Leukemia

Primary Purpose

Intervention/Treatment

- Type: OTHER
- Name: laboratory biomarker analysis
- Description: Correlative studies
- Arm Group Labels: Ancillary-Correlative (marker identification, molecular test)

Sponsor

Children's Oncology Group